Neumora Therapeutics IncNASDAQ:NMRA
- LAST PRICE12.9200
- TODAY'S CHANGE (%)0.1900 (1.4925%)
- Bid / Lots12.4700/ 1
- Ask / Lots13.9600/ 1
- Open / Previous Close12.8100 / 12.7300
- Day Range
- 52 Week Range
- Volume6,167,143
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | NMRA |
|---|---|---|
| 09:32 ET | 144763 | 12.651 |
| 09:34 ET | 400 | 12.81 |
| 09:36 ET | 550 | 12.825 |
| 09:38 ET | 617 | 12.86 |
| 09:39 ET | 632 | 12.84 |
| 09:41 ET | 426 | 12.795 |
| 09:43 ET | 1309 | 12.89 |
| 09:45 ET | 2488 | 12.69 |
| 09:48 ET | 100 | 12.695 |
| 09:50 ET | 464 | 12.75 |
| 09:52 ET | 1746 | 12.57 |
| 09:54 ET | 421 | 12.6 |
| 09:56 ET | 1100 | 12.565 |
| 09:57 ET | 3061 | 12.51 |
| 09:59 ET | 11678 | 12.52 |
| 10:01 ET | 491 | 12.57 |
| 10:03 ET | 1000 | 12.57 |
| 10:06 ET | 705 | 12.54 |
| 10:08 ET | 200 | 12.47 |
| 10:10 ET | 1375 | 12.525 |
| 10:12 ET | 900 | 12.55 |
| 10:14 ET | 952 | 12.49 |
| 10:15 ET | 527 | 12.5 |
| 10:17 ET | 1191 | 12.54 |
| 10:19 ET | 3256 | 12.62 |
| 10:21 ET | 1709 | 12.67 |
| 10:24 ET | 2323 | 12.81 |
| 10:26 ET | 300 | 12.74 |
| 10:28 ET | 1854 | 12.76 |
| 10:30 ET | 1263 | 12.845 |
| 10:32 ET | 1900 | 12.85 |
| 10:33 ET | 1678 | 12.7801 |
| 10:35 ET | 402 | 12.8 |
| 10:37 ET | 814 | 12.85 |
| 10:39 ET | 2077 | 12.87 |
| 10:42 ET | 200 | 12.88 |
| 10:44 ET | 300 | 12.85 |
| 10:46 ET | 5713 | 12.81 |
| 10:48 ET | 1150 | 12.82 |
| 10:50 ET | 1206 | 12.78 |
| 10:51 ET | 2494 | 12.825 |
| 10:55 ET | 936 | 12.8 |
| 10:57 ET | 100 | 12.78 |
| 11:00 ET | 3821 | 12.905 |
| 11:02 ET | 3996 | 12.84 |
| 11:04 ET | 1801 | 12.855 |
| 11:06 ET | 200 | 12.85 |
| 11:08 ET | 1300 | 12.9 |
| 11:11 ET | 600 | 12.88 |
| 11:13 ET | 6140 | 12.885 |
| 11:15 ET | 650 | 12.905 |
| 11:18 ET | 1651 | 12.89 |
| 11:20 ET | 1580 | 12.87 |
| 11:22 ET | 1931 | 12.85 |
| 11:24 ET | 2005 | 12.78 |
| 11:26 ET | 1058 | 12.775 |
| 11:27 ET | 2291 | 12.85 |
| 11:29 ET | 4521 | 12.84 |
| 11:31 ET | 1483 | 12.79 |
| 11:33 ET | 1252 | 12.77 |
| 11:36 ET | 1600 | 12.78 |
| 11:38 ET | 1550 | 12.83 |
| 11:40 ET | 1142 | 12.85 |
| 11:42 ET | 2307 | 12.865 |
| 11:44 ET | 2602 | 12.84 |
| 11:45 ET | 2020 | 12.84 |
| 11:47 ET | 1089 | 12.84 |
| 11:49 ET | 620 | 12.845 |
| 11:51 ET | 506 | 12.8 |
| 11:54 ET | 437 | 12.825 |
| 11:56 ET | 115 | 12.84 |
| 11:58 ET | 832 | 12.82 |
| 12:00 ET | 2340 | 12.85 |
| 12:02 ET | 638 | 12.85 |
| 12:03 ET | 833 | 12.82 |
| 12:05 ET | 200 | 12.83 |
| 12:07 ET | 937 | 12.85 |
| 12:09 ET | 1241 | 12.84 |
| 12:12 ET | 800 | 12.83 |
| 12:14 ET | 100 | 12.82 |
| 12:16 ET | 200 | 12.8 |
| 12:18 ET | 2758 | 12.785 |
| 12:20 ET | 412 | 12.78 |
| 12:21 ET | 2655 | 12.71 |
| 12:23 ET | 3415 | 12.75 |
| 12:25 ET | 200 | 12.77 |
| 12:27 ET | 400 | 12.77 |
| 12:30 ET | 6160 | 12.83 |
| 12:32 ET | 903 | 12.805 |
| 12:34 ET | 1497 | 12.815 |
| 12:36 ET | 1520 | 12.825 |
| 12:38 ET | 3350 | 12.76 |
| 12:39 ET | 100 | 12.765 |
| 12:41 ET | 3048 | 12.82 |
| 12:43 ET | 201 | 12.81 |
| 12:45 ET | 2524 | 12.83 |
| 12:48 ET | 100 | 12.82 |
| 12:50 ET | 4715 | 12.8 |
| 12:52 ET | 400 | 12.81 |
| 12:54 ET | 1489 | 12.79 |
| 12:56 ET | 450 | 12.77 |
| 12:57 ET | 2450 | 12.79 |
| 12:59 ET | 444 | 12.8 |
| 01:01 ET | 200 | 12.79 |
| 01:03 ET | 7701 | 12.775 |
| 01:06 ET | 2145 | 12.8 |
| 01:08 ET | 402 | 12.79 |
| 01:10 ET | 2100 | 12.83 |
| 01:12 ET | 250 | 12.83 |
| 01:14 ET | 2299 | 12.815 |
| 01:15 ET | 5463 | 12.82 |
| 01:17 ET | 1100 | 12.835 |
| 01:19 ET | 450 | 12.83 |
| 01:21 ET | 6880 | 12.83 |
| 01:24 ET | 949 | 12.82 |
| 01:26 ET | 800 | 12.815 |
| 01:28 ET | 2494 | 12.8 |
| 01:30 ET | 2097 | 12.765 |
| 01:32 ET | 1398 | 12.745 |
| 01:33 ET | 200 | 12.73 |
| 01:35 ET | 2978 | 12.745 |
| 01:37 ET | 3060 | 12.76 |
| 01:39 ET | 822 | 12.76 |
| 01:42 ET | 3284 | 12.72 |
| 01:44 ET | 1981 | 12.72 |
| 01:46 ET | 742 | 12.73 |
| 01:48 ET | 1973 | 12.745 |
| 01:50 ET | 609 | 12.745 |
| 01:51 ET | 1394 | 12.75 |
| 01:53 ET | 100 | 12.75 |
| 01:55 ET | 5748 | 12.74 |
| 01:57 ET | 623 | 12.73 |
| 02:00 ET | 2465 | 12.74 |
| 02:02 ET | 330 | 12.72 |
| 02:04 ET | 2300 | 12.75 |
| 02:06 ET | 1953 | 12.77 |
| 02:08 ET | 2916 | 12.81 |
| 02:09 ET | 7291 | 12.79 |
| 02:11 ET | 1447 | 12.795 |
| 02:13 ET | 1783 | 12.79 |
| 02:15 ET | 1152 | 12.795 |
| 02:18 ET | 436 | 12.79 |
| 02:20 ET | 3260 | 12.78 |
| 02:22 ET | 2872 | 12.81 |
| 02:24 ET | 400 | 12.81 |
| 02:26 ET | 1226 | 12.82 |
| 02:27 ET | 2800 | 12.84 |
| 02:29 ET | 1744 | 12.86 |
| 02:31 ET | 2238 | 12.84 |
| 02:33 ET | 1637 | 12.82 |
| 02:36 ET | 2672 | 12.81 |
| 02:38 ET | 661 | 12.8 |
| 02:40 ET | 1196 | 12.8 |
| 02:42 ET | 1943 | 12.82 |
| 02:44 ET | 100 | 12.83 |
| 02:45 ET | 6195 | 12.88 |
| 02:47 ET | 7194 | 12.95 |
| 02:49 ET | 1381 | 12.9536 |
| 02:51 ET | 806 | 12.96 |
| 02:54 ET | 1300 | 12.99 |
| 02:56 ET | 3962 | 12.975 |
| 02:58 ET | 3441 | 13 |
| 03:00 ET | 200 | 12.985 |
| 03:02 ET | 33391 | 13.02 |
| 03:03 ET | 18316 | 13.07 |
| 03:05 ET | 1542 | 13.065 |
| 03:07 ET | 1814 | 13.06 |
| 03:09 ET | 9583 | 13.08 |
| 03:12 ET | 450 | 13.085 |
| 03:16 ET | 1619 | 13.1 |
| 03:18 ET | 2839 | 13.12 |
| 03:20 ET | 2008 | 13.13 |
| 03:21 ET | 3900 | 13.15 |
| 03:23 ET | 4751 | 13.185 |
| 03:25 ET | 4556 | 13.16 |
| 03:27 ET | 1480 | 13.165 |
| 03:30 ET | 2100 | 13.18 |
| 03:32 ET | 3205 | 13.17 |
| 03:34 ET | 500 | 13.18 |
| 03:36 ET | 3348 | 13.2 |
| 03:38 ET | 6494 | 13.16 |
| 03:39 ET | 2268 | 13.19 |
| 03:41 ET | 2718 | 13.14 |
| 03:43 ET | 4043 | 13.21 |
| 03:45 ET | 4988 | 13.165 |
| 03:48 ET | 3851 | 13.14 |
| 03:50 ET | 5547 | 13.07 |
| 03:52 ET | 41240 | 13.11 |
| 03:54 ET | 8279 | 13.09 |
| 03:56 ET | 9770 | 13.09 |
| 03:57 ET | 105507 | 13.06 |
| 03:59 ET | 4064175 | 12.92 |
Sep 12, 2024
DJ Neumora Therapeutics Price Target Maintained With a $23.00/Share by Needham, from 1:41PM ET on Thursday Sep 12, 2024 by Dow Jones
1:41PM ET on Thursday Sep 12, 2024 by Dow Jones
Sep 4, 2024
DJ Neumora Therapeutics Price Target Maintained With a $29.00/Share by RBC Capital, from 10:06AM ET on Wednesday Sep 04, 2024 by Dow Jones
10:06AM ET on Wednesday Sep 04, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Neumora Therapeutics Inc | 2.0B | -7.8x | --- |
Soleno Therapeutics Inc | 2.0B | -21.2x | --- |
Centessa Pharmaceuticals PLC | 2.0B | -10.6x | --- |
Akero Therapeutics Inc | 1.9B | -8.2x | --- |
Rocket Pharmaceuticals Inc | 1.9B | -7.2x | --- |
Keros Therapeutics Inc | 2.2B | -10.9x | --- |
Company Information
Neumora Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company’s therapeutic pipeline consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its advanced product candidate, navacaprant (NMRA-140), is a novel once-daily oral kappa opioid receptor (KOR) antagonist that is being developed for the treatment of depressive disorder (MDD). Its other candidates include NMRA-266, NMRA-511, and NMRA-NMDA. NMRA-266 is a positive allosteric modulator program of the M4 muscarinic receptor (M4R) for the treatment of schizophrenia. NMRA-266 is designed to be selective for the M4 receptor subtype of the muscarinic receptor family. NMRA-511 is an investigational antagonist of the vasopressin 1a receptor (V1aR). NMRA-NMDA is an NMDA positive allosteric modulator program that the Company is developing for the treatment of schizophrenia.
Contact Information
- Headquarters
- 490 Arsenal Way, Suite 200WATERTOWN, MA, United States 02472
- Phone
- 857-760-0900
- Fax
- 302-655-5049
Executives
- Executive Chairman of the Board, Co-Founder
- Paul Berns
- President, Chief Executive Officer, Director
- Henry Gosebruch
- Co-Founder, Chief Operating Officer
- Carol Suh
- Chief Financial Officer
- Joshua Pinto
- Chief Strategy Officer
- Daljit Aurora
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.0B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 160.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.66 |
Book Value | $2.95 |
P/E Ratio | -7.8x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
